Enterprise Value
161.9M
Cash
12.56M
Avg Qtr Burn
-7.576M
Short % of Float
7.13%
Insider Ownership
6.81%
Institutional Own.
14.89%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
LYMPHIR (Denileukin Diftitox-cxdl, E7777) Details T-cell lymphoma Big Mover™ Suspected Mover™ Susp. Mover™ | PDUFA Approval decision | |
Mino-Lok Details Catheter related blood stream infections | Phase 3 Update | |
Halo-Lido (CITI-102) Details Hemorrhoids | Phase 2b Update |